title: Systemic lupus erythematosus.
authors.forename: P
authors.initials: P
authors.lastname: Stratta
authors.forename: C
authors.initials: C
authors.lastname: Canavese
authors.forename: S
authors.initials: S
authors.lastname: Santi
authors.forename: G
authors.initials: G
authors.lastname: Ciccone
authors.forename: S
authors.initials: S
authors.lastname: Rosso
mesh_terms: D016736:Antiphospholipid Syndrome / Q000188:drug therapy; D001379:Azathioprine / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D009369:Neoplasms / Q000453:epidemiology; D011241:Prednisone / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy
chemical_list: D005938:Glucocorticoids; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone